Shanghai, China

Lixia Han


 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Journey of Inventor Lixia Han

Introduction

Lixia Han is a notable inventor based in Shanghai, China, recognized for her contributions to pharmaceutical innovations. With a portfolio of three patents, she has made a significant impact in the field of medicinal chemistry, focusing on antiviral agents and therapeutic compounds.

Latest Patents

One of Lixia Han's most recent patents is the development of a modified compound of andrographolide. This patent discloses a compound represented in specific formulas, along with its pharmaceutically acceptable salts, which has the potential for various therapeutic applications. Another significant patent involves an imidazole derivative used as an antiviral agent. This compound is particularly promising for the preparation of medicaments aimed at treating respiratory syncytial virus infections, showcasing her role in combating viral diseases.

Career Highlights

Throughout her career, Lixia Han has worked with esteemed companies in the pharmaceutical sector, including Shandong Danhong Pharmaceutical Co., Ltd. and Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Her work in these companies reflects her commitment to advancing drug development and improving public health through innovative solutions.

Collaborations

Lixia Han has collaborated with several talented individuals in her field, including her coworkers Haiying He and Zhigan Jiang. These partnerships have fostered a creative environment where groundbreaking ideas and inventions can flourish.

Conclusion

In summary, Lixia Han is an exemplary inventor whose work continues to contribute significantly to the fields of medicine and pharmaceuticals. Through her latest patents and collaborations, she demonstrates the vital role of innovation in developing effective treatments for viral infections and enhancing healthcare solutions globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…